Takeda Pharmaceutical Co., Ltd. (TKPHF)
Q4 2018 Results Earnings Conference Call
May 14, 2019 4:00 AM ET
Company Participants
Andy Plump - Chief Medical & Scientific Officer and Director
Christophe Weber - Chief Executive Officer
Costa Saroukos - Chief Financial Officer
Julie Kim - President of Plasma-Derived Therapies Business Unit
Masato Iwasaki - President of Japan Pharma Business Unit & Director
Conference Call Participants
Hidemaru Yamaguchi - Citigroup
Kazuaki Hashiguchi - Daiwa Securities
Fumiyoshi Sakai - Crédit Suisse
Ritsuo Watanabe - Bank of America Merrill Lynch
Takashi Akahane - Tokai Tokyo
Presentation
Christophe Weber
Good